Supplemental material
Open access
1,788
Views
11
CrossRef citations to date
0
Altmetric
Research Paper
Subnanomolar indazole-5-carboxamide inhibitors of monoamine oxidase B (MAO-B) continued: indications of iron binding, experimental evidence for optimised solubility and brain penetration
Nikolay T. TzvetkovNTZ Lab Ltd., Sofia, Bulgaria; Correspondence[email protected]
& Liudmil AntonovBulgarian Academy of Sciences, Institute of Organic Chemistry, Centre of Phytochemistry, Sofia, Bulgaria
Pages 960-967
|
Received 02 May 2017, Accepted 07 Jun 2017, Published online: 20 Jul 2017
Related Research Data
Distribution of Monoamine Oxidase Proteins in Human Brain: Implications for Brain Imaging Studies
Source:
SAGE Publications
Impaired glutamate homeostasis and programmed cell death in a chronic MPTP mouse model of Parkinson's disease.
Source:
Elsevier BV
Evidence that formulations of the selective MAO-B inhibitor, selegiline, which bypass first-pass metabolism, also inhibit MAO-A in the human brain.
Source:
Springer Science and Business Media LLC
Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties
Source:
American Chemical Society (ACS)
Recent developments on the structure–activity relationship studies of MAO inhibitors and their role in different neurological disorders
Source:
Royal Society of Chemistry (RSC)
Selective MAO-A and B inhibitors, radical scavengers and nitric oxide synthase inhibitors in Parkinson's desease
Source:
Elsevier BV
Structure—Brain Exposure Relationships
Source:
Wiley
Monoamine oxidase expression during development and aging.
Source:
Elsevier BV
AChE Inhibition-based Multi-target-directed Ligands, a Novel Pharmacological Approach for the Symptomatic and Disease-modifying Therapy of Alzheimer's Disease.
Source:
Bentham Science Publishers Ltd.
Therapies in Parkinson's disease
Source:
Ovid Technologies (Wolters Kluwer Health)
Indazole- and indole-5-carboxamides: selective and reversible monoamine oxidase B inhibitors with subnanomolar potency.
Source:
American Chemical Society (ACS)
Recent progress in multifunctional metal chelators as potential drugs for Alzheimer's disease
Source:
Elsevier BV
Ligand efficiency indices for effective drug discovery
Source:
Informa Healthcare
Substantial improvements in large-scale redocking and screening using the novel HYDE scoring function
Source:
Springer Science and Business Media LLC
Miniperspective
Source:
American Chemical Society (ACS)
Multi-targeted directed ligands for Alzheimer’s disease: design of novel lead coumarin conjugates
Source:
Informa UK Limited
Clinical pharmacology review of safinamide for the treatment of Parkinson’s disease
Source:
Future Medicine Ltd
Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.
Source:
Elsevier BV
Structures of Human Monoamine Oxidase B Complexes with Selective Noncovalent Inhibitors: Safinamide and Coumarin Analogs.
Source:
American Chemical Society (ACS)
Monoamine oxidase-B inhibitors as potential neurotherapeutic agents: An overview and update
Source:
Wiley
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.